Calif. institute strategic plan sees no stem cell cures soon

California's $3 billion stem cell institute is not likely to offer any medical cures for at least another 10 years, according to a group assigned to draft a strategic plan. The group's proposal, which must be approved by the California Institute for Regenerative Medicine, spells out a method for eventually turning stem cells into treatments and anticipates early studies on potential cures having just begun before the funds run out.

View Full Article in:

San Jose Mercury News (Calif.) (free registration) · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI